Aurore Life Sciences
Aurore Life Sciences (India) holds 35 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 34 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Aurore Life Sciences: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/aurore-life-sciences
Overview
Aurore Life Sciences is a pharmaceutical company headquartered in Hyderabad, India.
Active ingredients with DMF or CEP filings
Substances for which Aurore Life Sciences holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Aurore Life Sciences holds 35 active (35 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- BILASTINE (FORM-I)Active2023-10-10
- TAFAMIDISActive2022-10-18
- TAFAMIDIS MEGLUMINEActive2022-06-03
- DABIGATRAN ETEXILATE MESILATEActive2022-04-06
- INDOMETHACIN USPActive2022-02-03
- SULINDACActive2022-02-03
- CLOZAPINE USPActive2021-12-23
- FAVIPIRAVIR [ROUTE CODE- FRR]Active2021-11-15
- RALOXIFENE HYDROCHLORIDE USPActive2021-10-23
- MOLNUPIRAVIRActive2021-09-30
- ACYCLOVIR USP [SITE KHAZIPALLY]Active2021-09-29
- VALACYCLOVIR HYDROCHLORIDE USPActive2021-08-20
- NAFAMOSTAT MESILATE JPActive2021-07-03
- DRONEDARONE HYDROCHLORIDE USPActive2021-05-31
- TOFACITINIB CITRATEActive2021-04-26
- FLUPHENAZINE HYDROCHLORIDE USPActive2021-03-27
- FAVIPIRAVIRActive2021-03-22
- FESOTERODINE FUMARATEActive2021-03-05
- PRAZOSIN HYDROCHLORIDE USPActive2020-12-31
- MARBOFLOXACINActive2020-12-31
- LEVETIRACETAM FORM-I USPActive2020-10-12
- LOSARTAN POTASSIUM USPActive2020-09-01
- VALACYCLOVIR HYDROCHLORIDE USPActive2020-03-20
- VALGANCICLOVIR HYDROCHLORIDE USPActive2020-02-26
- SALSALATE USPActive2020-01-29
- ACYCLOVIR USPActive2020-01-28
- OXCARBAZEPINE USPActive2019-12-31
- DESVENLAFAXINE SUCCINATE USPActive2019-12-19
- TOLVAPTANActive2019-12-05
- TOLVAPTAN AMORPHOUSActive2019-11-30
- AMLODIPINE BESYLATE USPActive2019-11-22
- LEVETIRACETAM USPActive2019-08-26
- CELECOXIB USPActive2019-08-08
- LEVOTHYROXINE SODIUM USPActive2019-08-05
- VERAPAMIL HYDROCHLORIDE USPActive2019-07-31
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to Aurore Life Sciences, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Aurore Life Sciences in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Aurore Life Sciences?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.